Replies to post #201822 on OWC Pharmaceutical Research Corp (OWCP)

[CanItBThisEZ2Make]

My DD shows that Kugelman will save the Company or re-organize it. Shareholders won't matter. However shareholders will be first to know about the new first. So after whatever happens, it would be wise to have funds ready for the new.

[PhenixBleu]

VI.The Public Interest Would Not Be Disserved By A Permanent Injunction

Finally, the undisputed evidence demonstrates that the public interest would not be disserved by a permanent injunction. Defendant’s common stock currently trades on the over-the-counter OTC Market under the ticker symbol “OWCP”. SOF 2. As reflected on its listing on OTC Markets, OWCP is currently listed as “Pink No Information” or “Stop Sign”, due to “Delinquent SEC Reporting”. Id. 33. As a result, the listing states: “Warning! This company may not be making material information publicly available. Id. Buying or selling a security on the basis of material nonpublic material information is prohibited under Section 10(b) of the Securities Exchange Act of 1934 and Rules 10b-5 and 10b5-1 thereunder. Violators may be subject to civil and criminal penalties.” Id. Far from being disserved by a permanent injunction, the public would be served by having access to OWCP’s financial information, permitting it to trade OWCP’s Common Stock with the benefit of full and accurate information.

Reference Docket Entry 27 - Memorandum of Law in Support of Motion for Summary Judgement

Clearly, DGF does not have access to all of OWC Israel's records. Shareholders deserve facts on which they can trade.

We've known for months now that David Kugelman and John Kirkland already have the keys to the domain. All that remains to be seen is whether or not there is anything left after they pay off and/or negotiate their debts.